Pharmafile Logo

Inizio appoints Ryan Quigley as CEO

September 10, 2025 | Inizio, News 

- PMLiVE

Inizio have appointed Ryan Quigley as Chief Executive Officer, effective 9 September 2025. Paul Taaffe will remain closely involved with the company as an Advisor and board member going forward. 

Ryan has served as Chief Operating Officer since 2021, driving Inizio’s commercial strategy, innovation agenda, and investment roadmap – playing a pivotal role in developing the organization into the leading commercialization partner to health and life sciences companies worldwide. 

This transition marks an important moment in Inizio’s journey. Read the full news piece here.   

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Digital research in Asia

Director Marc Yates uses findings from a study conducted in six markets in Asia to explore how digital channels are being utilised by consumers and look at the digital opportunities…

Achieving customer centricity – Using immersion techniques to get closer to the pulse of the customer

Director Marc Yates discusses the importance of being customer-centric in the pharmaceutical industry and how immersion techniques in market research can help develop a better understanding of the customer.

The Mobile Revolution – Using mobile Apps to deliver “in-the-moment” market research to global healthcare

Director John Branston investigates the use of mobile research in order to capture immediate detailed, qualitative insights into prescription rationale at the patient level.